Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2015, Article ID 729567, 7 pages
Clinical Study

A Novel Multidisciplinary Intervention for Long-Term Weight Loss and Glycaemic Control in Obese Patients with Diabetes

1Department of Endocrinology & Metabolism, Concord Repatriation General Hospital, Rhodes, NSW 2139, Australia
2Sydney Medical School, University of Sydney, Sydney, NSW 2006, Australia
3University of New South Wales Medical Program, University of New South Wales, Sydney, NSW 2052, Australia
4Department of Vascular Medicine, St. Vincent’s Hospital, Darlinghurst, Sydney, NSW 2010, Australia
5School of Nursing and Midwifery, University of Western Sydney, Campbelltown, NSW 2560, Australia
6School of Medicine, University of Adelaide, Adelaide, SA 5005, Australia

Received 9 February 2015; Accepted 25 March 2015

Academic Editor: Francis M. Finucane

Copyright © 2015 Anna Lih et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Introduction. Obesity and diabetes are difficult to treat in public clinics. We sought to determine the effectiveness of the Metabolic Rehabilitation Program (MRP) in achieving long-term weight loss and improving glycaemic control versus “best practice” diabetes clinic (DC) in obese patients using a retrospective cohort study. Methods. Patients with diabetes and BMI > 30 kg/m2 who attended the MRP, which consisted of supervised exercise and intense allied health integration, or the DC were selected. Primary outcomes were improvements in weight and glycaemia with secondary outcomes of improvements in blood pressure and lipid profile at 12 and 30 months. Results. Baseline characteristics of both cohorts (40 MRP and 40 DC patients) were similar at baseline other than age (63 in MRP versus 68 years in DC, ). At 12 months, MRP patients lost 7.65 ± 1.74 kg versus 1.76 ± 2.60 kg in the DC group () and 9.70 ± 2.13 kg versus 0.98 ± 2.65 kg at 30 months (). Similarly, MRP patients had significant absolute reductions in %HbA1c at 30 months versus the DC group (−0.86 ± 0.31% versus 0.12% ± 0.33%, ), with nonsignificant improvements in lipids and blood pressure in MRP patients. Conclusion. Further research is needed to establish the MRP as an effective strategy for achieving sustained weight loss and improving glycaemic control in obese patients with type 2 diabetes.